Gevo, Inc.

NASDAQ:GEVO

Chemicals - Specialty

Basic Materials
$1.70 +2.68%

+$0.04 today

Market cap
$420.54M
Beta
0.99
P/E (TTM)
-10.7
EPS (TTM)
-$0.14
52W Low $1.12High $2.97

Volume 2.74M

Average 3.88M

GEVO Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Gevo, Inc.NASDAQ: GEVO

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q1 FY2026 research & development of $4.54M rose 331.5% year over year, ahead of the +195.4% change in trailing-twelve-month research & development. Sequentially, it rose 16.9% from the prior quarter. Over 3 fiscal years it compounded at -36.2% a year.

Context

  • Research & development amounted to 2.8% of revenue in FY2025, down 137.5 pp from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +331.5% holds above the trailing-twelve-month pace of +195.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.54M+16.9% QoQ
Last fiscal yearDec 2025
$4.55M-80.8% YoY
LTMMar 2026
$10.63M+195.4% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+331.5%——
1 year-80.8%——
3-year CAGR-36.2%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
4.55M USD
Year-over-year change
-80.8%
4-year CAGR
-28.4%

Research & Development vs competitors

How GEVO compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +195.4% is the highest of 7, against a peer median of -61.1%.
  • Research & development amounts to 6.1% of revenue for GEVO, versus a peer median of 0.0%.
GEVO Competitors
Research & Development for GEVO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MATVMativ Holdings, Inc.LTM Mar 2026$22.8M USD-2.1%+7.9%1.2%
LWLGLightwave Logic, Inc.LTM Mar 2026$11.89M USD-22.2%-3.5%4891.2%
GEVOGevo, Inc.LTM Mar 2026$10.63M USD+195.4%-36.2%6.1%
ADURAduro Clean Technologies Inc.LTM Feb 2026CA$7.36M CAD+38.8%+73.9%3044.1%
KROKronos Worldwide, Inc.LTM Mar 2026$0 USD——0.0%
GPREGreen Plains Inc.LTM Mar 2026$0 USD-100.0%—0.0%
LXULSB Industries, Inc.LTM Mar 2026$0 USD——0.0%
KOPKoppers Holdings Inc.LTM Mar 2026$0 USD——0.0%
NFGCNew Found Gold Corp.LTM Mar 2026CA$0 CAD-100.0%—0.0%
ASIXAdvanSix Inc.LTM Mar 2026$0 USD——0.0%
TROXTronox Holdings plcLTM Mar 2026$0 USD-100.0%+7.7%0.0%
Peer median (excluding GEVO) —-61.1%+7.8%0.0%

Competitors are the stored peer set for GEVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue533K1.18M17.2M16.92M160.58M
Cost of Revenue7.69M8.7M11.99M12M112.04M
Gross Profit(7.15M)(7.52M)5.21M4.91M48.54M
Gross Margin-1342.2%-640.3%30.3%29.0%30.2%
Research & Development17.36M17.49M6.64M23.74M4.55M
Selling, General & Admin25.49M39.94M42.63M45.8M51.2M
Operating Expenses53.11M95.16M87.04M95.74M67.41M
Depreciation & Amortization5.13M7.89M19.01M18.3M25.32M
EBITDA(53.82M)(88.95M)(45.05M)(56.46M)10.25M
EBITDA Margin-10098.3%-7570.5%-261.9%-333.8%6.4%
Operating Income(60.27M)(102.69M)(81.84M)(90.82M)(18.87M)
Operating Margin-11307.3%-8739.2%-475.8%-536.9%-11.7%
Interest Income571K3.48M19.09M15.74M7.81M
Interest Expense251K1.17M2.16M3.88M17.56M
Other Income / Expenses1.07M4.68M15.62M12.18M(13.76M)
Income Before Tax(59.2M)(98.01M)(66.22M)(78.64M)(32.63M)
Pre-Tax Margin-11107.5%-8341.0%-385.0%-464.9%-20.3%
Income Tax Expense00000
Net Income(59.2M)(98.01M)(66.22M)(78.64M)(33.84M)
Net Margin-11107.5%-8341.0%-385.0%-464.9%-21.1%
EPS (Basic)(0.30)(0.44)(0.28)(0.34)(0.14)
EPS (Diluted)(0.30)(0.44)(0.28)(0.34)(0.14)
Weighted Avg Shares195.79M221.54M238.69M231.67M234.01M
Weighted Avg Shares (Diluted)195.79M221.54M238.69M231.67M234.01M

Gevo, Inc.

NASDAQ:GEVO

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.